Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: A simple, fast and inexpensive automated technique

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 3, 2005, Pages 294-297

  Selmeci, László ^a   Seres, Leila ^a   Antal, Magda ^b   Lukács, Júlia ^c   Regöly Mérei, Andrea ^b   Acsády, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Public Health Center   (Hungary)

^c Roche Hungary Ltd   (Hungary)

Author keywords

Advanced oxidation protein products (AOPP); Critically ill patients; Oxidative stress measurement; Reactive oxygen species (ROS)

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ANALYTIC METHOD; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HEART FAILURE; HUMAN; HUMAN EXPERIMENT; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; REPERFUSION INJURY; SEPSIS; UREMIA;

ADOLESCENT; ADULT; AUTOMATION; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 17044398975     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.050     Document Type: Article

References (16)

1. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41:1819-28.
2. Gutteridge JM, Mitchell J. Redox imbalance in the critically ill. Br Med Bull 1999;55:49-75.
3. Goodyear-Bruch C, Pierce JD. Oxidative stress in critically ill patients. Am J Crit Care 2002;11:543-51.
4. DE Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage. Applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-26.
5. Del Rio D, Serafini M, Pellegrini N. Selected methodologies to assess oxidative/antioxidant status in vivo: a critical review. Nutr Metab Cardiovasc Dis 2002;12:343-51.
6. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-13.
7. Witko V, Nguyen AT, Descamps-Latscha B. Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal 1992;6:47-53.
8. Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004;1689:91-102.
9. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002;162:221-5.
10. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000;47:221-4.
11. Buonocore G, Perrone S, Longini M, Vezzosi P, Marzocchi B, Paffetti P, et al. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res 2002;52:46-9.
12. Kalousova M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002; 51:597-604.
13. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-74.
14. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am J Med 2004; 116:595-600.
15. Sebekova K, Gazdikova K, Syrova D, Blazicek P, Schinzel R, Heidland A, et al. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidative stress and potential modulation of advanced glycation end products. J Hum Hypertens 2003;17:265-70.
16. Matteucci E, Biasci E, Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol 2001;38:187-9.